Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Liver Diseases × Nadroparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Carcinoma, Hepatocellular 1 Adenocarcinoma 1

Interventions

halofantrine 1 Nadroparin 1 Microspheres 1 Heparin, Low-Molecular-Weight 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡